(WASHINGTON) #Coronavirus Remdesivir Drug Report: Trump administration says it has locked down nearly the entire supply of one of the only available anti-#COVID19 drugs from the manufacturer for the next several months: That raises questions about access to one of the few treatments for much of the rest of the world and rumours about charges in the U.S. of $3,000 according to CNBC even though manufacturer Cipla says they will charge $66.00 #AceHealthDesk

#AceHealthReport – July.01: Remdesivir is the first drug shown to help patients with #COVID19 though its impact is modest: Hospitalised patients given the drug recovered four days faster than those given a placebo: https://www.nejm.org/doi/full/10.1056/NEJMoa2007764 “Preliminary results did not show that it saved lives, but the study is ongoing. The U.S. Department of https://www.hhs.gov/about/news/2020/06/29/trump-administration-secures-new-supplies-remdesivir-united-states.html” Health and Human Services</a> announced Monday that it had secured half a million treatment courses of the antiviral drug from its manufacturer, U.S. pharmaceutical company Gilead Sciences, including 100% of the company’s production for July and 90% for August and September:

#Coronavirus Report: U.S Trump Admin acquires all of Remdesivir from Gilead for next few months at a charge the manufacturer Cipla says It will charge $66.00 but #coronavirus treatment remdesivir to cost $3,120 per U.S. patient with private insurance CNBC reports

https://acenewsroom.wordpress.com/2020/06/30/coronavirus-report-gileads-coronavirus-treatment-remdesivir-to-cost-3120-per-u-s-patient-with-private-insurance-cnbc-reports/

AceNewsDesk_Bot, [Jun 30, 2020 at 19:23]

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for COVID-19,” HHS Secretary Alex Azar said in a statement: https://im-media.voltron.voanews.com/Drupal/01live-166/styles/sourced/s3/2020-05/000_1QH0VL.jpg?itok=Asma3pbn” Vials of the drug remdesivir lie during a press conference about the start of a study with the Ebola drug Remdesivir: Vials of the drug remdesivir are seen at a hospital in Germany, April 8, 2020: https://www.gilead.com/purpose/advancing-global-health/covid-19/voluntary-licensing-agreements-for-remdesivir” Gilead signed licensing agreements with generic manufacturers in India, Pakistan and Egypt to supply remdesivir to 127 mainly low- and middle-income countries: But that license excludes more than 70 large middle-income countries, including Brazil, Mexico and China. “That adds up to half the world’s population,” noted Peter Maybarduk, director of the access to medicines program at the advocacy group Public Citizen. ”

If the U.S. government has bought up the supply, then I don’t know where they’d get” the drug, he added: It is not clear whether generic manufacturers can fill the needs in the other 127 countries. Only two Indian companies have begun producing the drug so far. “I think it is safe to assume that two companies alone could not currently supply all of the demand,” Jessica Burry, pharmacist for the Access Campaign at medical humanitarian group Doctors Without Borders, said in a statement to VOA. “Gilead does not seem to have any plan to sufficiently supply low- and middle-income countries’ markets during this interim period while generics are coming on board, either, as they seem more focused on high-income country markets where they can make more money,” she added: The drug will cost about $3,200 per treatment course in the United States, a price

https://www.citizen.org/news/gileads-remdesivir-price-is-offensive/” Maybarduk calls “offensive Indian generic https://www.reuters.com/article/us-health-coronavirus-cipla/indias-cipla-to-price-remdesivir-version-for-covid-19-under-66-idUSKBN23U1PQ” manufacturer Cipla said it will charge around $66:

https://icer-review.org/blog/icer-comments-on-gileads-pricing-for-remdesivir/ Institute for Clinical and Economic Review the drug pricing watchdog, said Gilead’s price is “reasonable,” provided the drug ultimately shows it can save lives: Gilead donated the first 1.5-million free:

#AceHealthDesk report ………………..Published: July.01: 2020:

Editor says #AceNewsDesk reports by https://t.me/acenewsdaily and all our posts, links can be found at here Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com